178,927 CVS Health Corporation $CVS Shares Sold by Canoe Financial LP

Canoe Financial LP trimmed its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,014,906 shares of the pharmacy operator's stock after selling 178,927 shares during the period. CVS Health comprises approximately 2.1% of Canoe Financial LP's portfolio, making the stock its 16th biggest holding. Canoe Financial LP owned about 0.16% of CVS Health worth $171,687,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Elevation Wealth Partners LLC lifted its holdings in shares of CVS Health by 41.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator's stock valued at $37,000 after buying an additional 105 shares during the last quarter. HBW Advisory Services LLC raised its position in CVS Health by 3.5% during the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator's stock valued at $292,000 after acquiring an additional 115 shares in the last quarter. Apella Capital LLC raised its position in CVS Health by 1.7% during the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator's stock valued at $724,000 after acquiring an additional 117 shares in the last quarter. Wellington Altus USA Inc. lifted its stake in CVS Health by 13.3% in the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator's stock valued at $106,000 after acquiring an additional 120 shares during the last quarter. Finally, CoreCap Advisors LLC lifted its stake in CVS Health by 4.2% in the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator's stock valued at $360,000 after acquiring an additional 139 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS is expanding access through smaller, pharmacy-focused store formats in underserved communities. The strategy is intended to align locations with prescription demand, improve operating efficiency and support pharmacy growth. How Small Pharmacy Expansion Will Impact CVS Health Investors
• Positive Sentiment: MinuteClinic opened three new Massachusetts locations, including the first in Boston, broadening CVS’s retail healthcare footprint and potentially increasing patient traffic and service revenue. MinuteClinic Opens Three New Retail Medical Clinics
• Positive Sentiment: CVS is seeking to capture customers from Walgreens and Rite Aid as competitors close stores. The opportunity could support prescription volumes and strengthen CVS’s local market share. CVS Targets Former Walgreens and Rite Aid Customers
• Positive Sentiment: Aetna is streamlining prior authorizations, reporting that more than 95% of eligible requests are approved within 24 hours. Faster approvals may improve member experience and reduce administrative friction, although the direct financial effect is not yet quantified. How CVS Aetna Is Reducing Administrative Burden

Analysts Set New Price Targets

CVS has been the subject of several recent research reports. UBS Group reissued a "buy" rating on shares of CVS Health in a research report on Tuesday, September 22nd. Barclays raised their price target on shares of CVS Health from $106.00 to $108.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. Wall Street Zen downgraded shares of CVS Health from a "strong-buy" rating to a "buy" rating in a report on Monday. Argus lifted their price objective on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a research note on Wednesday, August 19th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $107.80.

CVS Health Trading Down 1.2%

NYSE:CVS opened at $93.62 on Thursday. The company's 50 day moving average is $91.68 and its 200-day moving average is $93.63. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The firm has a market cap of $119.74 billion, a price-to-earnings ratio of 24.77, a P/E/G ratio of 0.88 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be paid a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health's payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation NYSE: CVS is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company's Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.